Evidence map›Paper›PMID 38519813›Full record

ArticlePharmaceutical research2024

Identification of Surfactant Impact on a Monoclonal Antibody Characterization via HPLC-Separation Based and Biophysical Methods.

Kaizhu Guo, Jing Song, Petra Bennington, Alexander J Pavon, Jameson R Bothe, Hanmi Xi, Rico C Gunawan

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kaizhu GuoBiologics Analytical Research and Development, Merck & Co., Inc., Rahway, NJ, 07065, USA. kaizhu.guo@merck.com.ORCID http://orcid.org/0000-0001-5545-9941
Jing SongAnalytical Enabling Capabilities, Merck & Co., Inc., Rahway, NJ, 07065, USA. jing.song1@merck.com.ORCID http://orcid.org/0009-0000-7535-1399
Petra BenningtonCell-Based Sciences, Analytical Research and Development, Merck & Co., Inc., Rahway, NJ, 07065, USA.ORCID http://orcid.org/0009-0007-4495-8252
Alexander J PavonBiologics Analytical Research and Development, Merck & Co., Inc., Rahway, NJ, 07065, USA.ORCID http://orcid.org/0000-0003-2062-6695
Jameson R BotheBiologics Analytical Research and Development, Merck & Co., Inc., Rahway, NJ, 07065, USA.ORCID http://orcid.org/0000-0002-1753-0994
Hanmi XiAnalytical Enabling Capabilities, Merck & Co., Inc., Rahway, NJ, 07065, USA.ORCID http://orcid.org/0000-0002-5102-792X
Rico C GunawanBiologics Analytical Research and Development, Merck & Co., Inc., Rahway, NJ, 07065, USA.ORCID http://orcid.org/0000-0003-1659-1653
Merck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PURPOSE OR

objectiveSurfactants, including polysorbates and poloxamers, play a crucial role in the formulation of therapeutic proteins by acting as solubilizing and stabilizing agents. They help prevent protein aggregation and adsorption, thereby enhancing the stability of drug substance and products., However, it is important to note that utilizing high concentrations of surfactants in protein formulations can present significant analytical challenges, which can ultimately affect the product characterization.

methodsIn our study, we specifically investigated the impact of elevated surfactant concentrations on the characterization of monoclonal antibodies. We employed various analytical techniques including size-exclusion chromatography (SEC), capillary electrophoresis (CE-SDS), a cell based functional assay, and biophysical characterization.

resultsThe findings of our study indicate that higher levels of Polysorbate 80 (PS-80) have adverse effects on the measured purity, biological activity, and biophysical characterization of biologic samples. Specifically, the elevated levels of PS-80 cause analytical interferences, which can significantly impact the accuracy and reliability of analytical studies.

conclusionsOur study results highlight a significant risk in analytical investigations, especially in studies involving the isolation and characterization of impurities. It is important to be cautious of surfactant concentrations, as they can become more concentrated during common sample manipulations like buffer exchange. Indeed, the research presented in this work emphasizes the necessity to evaluate the impact on analytical assays when there are substantial alternations in the matrix composition. By doing so, valuable insights can be gained regarding potential challenges associated with assay development and characterization of biologics with complex formulations.

Indexed as

Antibodies, MonoclonalSurface-Active AgentsChromatography, High Pressure LiquidLipoproteinsPolysorbatesReproducibility of ResultsAntibodies, MonoclonalLipoproteinsPolysorbatesSurface-Active Agentsanalytical characterization methodsmonoclonal antibodypolysorbate 80surfactant

Identifiers

PMID38519813
OpenAlexW4393094560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.